Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Adaptimmune therapeutics plc symbols : GSK save search
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
Published: 2023-04-11 (Crawled : 15:20) - biospace.com/
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: -1.27%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: -1.77%
H: 11.71%
C: 9.01%
transfer back
Cancer Gene Therapy Market To Reach a Valuation of USD 4047.8 Million by 2028 - Comprehensive Research Report by BrandEssence Market Research
Published: 2022-12-02 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: -3.13%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -0.61%
H: 0.08%
C: -0.29%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.08%
H: 1.44%
C: 1.28%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.29%
H: 1.55%
C: 1.2%
CRNX G | $43.32 -2.04% -2.08% 420K
|
Health Technology
|
| O: -0.57%
H: 5.9%
C: 5.44%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.23%
H: 0.79%
C: 0.43%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: -0.99%
H: 6.5%
C: 3.0%
research report therapy cancer market
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 6.22%
H: 3.13%
C: -0.56%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 1.22%
H: 0.01%
C: -1.7%
IOVA 4 | $11.69 -1.43% -1.45% 2.7M
|
Health Technology
|
| O: 6.12%
H: 4.99%
C: 4.21%
INO | $10.1 -2.6% -2.67% 250K
|
Health Technology
|
| O: 5.5%
H: 4.35%
C: 3.48%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 1.43%
H: 0.36%
C: -1.08%
ATRA | $0.7101 -1.18% -1.2% 700K
|
Health Technology
|
| O: 2.58%
H: 23.12%
C: 20.85%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 7.08%
H: 0.84%
C: -0.43%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: 0.0%
H: 7.14%
C: 5.71%
covid-19 research global immunotherapy report impact technology market
Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published: 2022-06-27 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.47%
H: 3.73%
C: 3.73%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.16%
H: 0.61%
C: 0.18%
CRNX G | $43.32 -2.04% -2.08% 420K
|
Health Technology
|
| O: 0.66%
H: 1.22%
C: -5.83%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.08%
H: 0.45%
C: -0.13%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: 1.85%
H: 6.67%
C: 3.03%
treatment therapy cancer market
Sarcoma Therapeutics Market 2022-2026 | Patient Assistance Programs to Boost Growth | Technavio
Published: 2022-02-28 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -3.4%
H: 7.54%
C: 7.54%
CYTR | $0.092
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -3.12%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: 0.1%
H: 0.1%
C: -1.62%
AGEN A | $7.42 14.86% 12.94% 1.3M
|
Health Technology
|
| O: -1.31%
H: 0.0%
C: 0.0%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: -1.86%
H: 4.92%
C: -1.52%
program therapeutics growth
Insights on the Kidney Cancer Diagnostics and Therapeutics Global Market to 2026 - Key Motivators, Restraints and Opportunities
Published: 2021-08-05 (Crawled : 16:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.42%
H: 0.31%
C: 0.13%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: 0.24%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.69%
H: 0.37%
C: 0.34%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.14%
H: 0.3%
C: 0.22%
EXEL | $23.7 1.76% 1.73% 1.5M
|
Health Technology
|
| O: 0.0%
H: 2.03%
C: 1.25%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.48%
H: 0.46%
C: 0.43%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: 0.58%
H: 4.05%
C: 2.02%
cancer diagnostics kidney diagnostic
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.